RON COHEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RON COHEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RON COHEN. RON COHEN is in DYAX CORP ($DYAX) and Director in DYAX CORP ($DYAX) and President and CEO in ACORDA THERAPEUTICS INC ($ACOR).
Latest Insider Trading Transactions of RON COHEN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2021 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 29,000 | 0 | 135,830 | 106.8 K to 135.8 K (+27.15 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 8,543 | 0 | 640,980 | 632.4 K to 641 K (+1.35 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 1.60 | 4,699 | 7,505 | 607,287 | 612 K to 607.3 K (-0.77 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 1.60 | 4,699 | 7,505 | 607,287 | 612 K to 607.3 K (-0.77 %) |
Nov 12 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 2.41 | 218,500 | 526,585 | 218,500 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 13.51 | 42,715 | 577,080 | 42,715 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 25,629 | 0 | 517,136 | 491.5 K to 517.1 K (+5.21 %) |
Feb 25 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Payment of Exercise | F | 13.38 | 2,027 | 27,121 | 491,507 | 493.5 K to 491.5 K (-0.41 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 5,980 | 0 | 493,534 | 487.6 K to 493.5 K (+1.23 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.60 | 3,620 | 74,554 | 487,554 | 491.2 K to 487.6 K (-0.74 %) |
Nov 07 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Payment of Exercise | F | 20.28 | 2,031 | 41,189 | 491,174 | 493.2 K to 491.2 K (-0.41 %) |
Sep 12 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 5,980 | 0 | 493,205 | 487.2 K to 493.2 K (+1.23 %) |
Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 19.81 | 62,500 | 1,238,125 | 0 | |
Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Payment of Exercise | F | 25.95 | 24,590 | 638,111 | 564,285 | 588.9 K to 564.3 K (-4.18 %) |
Mar 07 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 19.81 | 62,500 | 1,238,125 | 588,875 | 526.4 K to 588.9 K (+11.87 %) |
Feb 26 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 14,727 | 0 | 526,375 | 511.6 K to 526.4 K (+2.88 %) |
Jun 20 2017 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | P | 16.95 | 20,000 | 338,998 | 511,648 | 491.6 K to 511.6 K (+4.07 %) |
Dec 16 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 15.49 | 40,172 | 622,264 | 0 | |
Dec 16 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 21.35 | 408 | 8,711 | 479,688 | 480.1 K to 479.7 K (-0.08 %) |
Dec 16 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.75 | 39,764 | 824,944 | 480,096 | 519.9 K to 480.1 K (-7.65 %) |
Dec 16 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 15.49 | 40,172 | 622,264 | 519,860 | 479.7 K to 519.9 K (+8.37 %) |
Dec 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.74 | 7,160 | 148,482 | 479,688 | 486.8 K to 479.7 K (-1.47 %) |
Mar 04 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 35.53 | 68,726 | 2,441,835 | 68,726 | |
Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 15.49 | 10,591 | 164,055 | 40,172 | |
Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 6.00 | 4,005 | 24,030 | 0 | |
Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 5.85 | 14,642 | 85,656 | 0 | |
Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 15.49 | 10,591 | 164,055 | 429,788 | 419.2 K to 429.8 K (+2.53 %) |
Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 6.00 | 4,005 | 24,030 | 419,197 | 415.2 K to 419.2 K (+0.96 %) |
Feb 05 2016 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 5.85 | 14,642 | 85,656 | 415,192 | 400.6 K to 415.2 K (+3.66 %) |
Jan 22 2016 | DYAX | DYAX CORP | COHEN RON | Option Exercise | D | 26.23 | 16,667 | 437,175 | 0 | ||
Jan 22 2016 | DYAX | DYAX CORP | COHEN RON | Sell | D | 0.00 | 133,333 | 0 | 0 | 133.3 K to 0 (-100.00 %) | |
Jan 19 2016 | DYAX | DYAX CORP | COHEN RON | Director | Option Exercise | M | 26.23 | 33,333 | 874,325 | 16,667 | |
Jan 19 2016 | DYAX | DYAX CORP | COHEN RON | Director | Option Exercise | M | 1.51 | 75,000 | 113,250 | 0 | |
Jan 19 2016 | DYAX | DYAX CORP | COHEN RON | Director | Option Exercise | M | 1.35 | 25,000 | 33,750 | 0 | |
Jan 19 2016 | DYAX | DYAX CORP | COHEN RON | Director | Buy | M | 26.23 | 33,333 | 874,325 | 133,333 | 100 K to 133.3 K (+33.33 %) |
Jan 19 2016 | DYAX | DYAX CORP | COHEN RON | Director | Buy | M | 1.51 | 75,000 | 113,250 | 100,000 | 25 K to 100 K (+300.00 %) |
Jan 19 2016 | DYAX | DYAX CORP | COHEN RON | Director | Buy | M | 1.35 | 25,000 | 33,750 | 25,000 | 0 to 25 K |
Dec 03 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 38.08 | 11,850 | 451,225 | 400,550 | 412.4 K to 400.6 K (-2.87 %) |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 15.49 | 910 | 14,096 | 50,763 | |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 15.49 | 54,421 | 842,981 | 51,673 | |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 8.50 | 500 | 4,250 | 0 | |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 5.85 | 70,358 | 411,594 | 14,642 | |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 6.00 | 8,811 | 52,866 | 4,005 | |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 30.10 | 910 | 27,391 | 412,400 | 413.3 K to 412.4 K (-0.22 %) |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 15.49 | 910 | 14,096 | 413,310 | 412.4 K to 413.3 K (+0.22 %) |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 28.01 | 134,090 | 3,756,142 | 412,400 | 546.5 K to 412.4 K (-24.54 %) |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 15.49 | 54,421 | 842,981 | 546,490 | 492.1 K to 546.5 K (+11.06 %) |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 8.50 | 500 | 4,250 | 492,069 | 491.6 K to 492.1 K (+0.10 %) |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 5.85 | 70,358 | 411,594 | 491,569 | 421.2 K to 491.6 K (+16.70 %) |
Oct 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 6.00 | 8,811 | 52,866 | 421,211 | 412.4 K to 421.2 K (+2.14 %) |
May 14 2015 | DYAX | DYAX CORP | COHEN RON | Director | Option Exercise | A | 26.23 | 50,000 | 1,311,500 | 50,000 | |
Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 35.74 | 94,000 | 3,359,560 | 94,000 | |
Mar 06 2015 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 17,000 | 0 | 512,400 | 495.4 K to 512.4 K (+3.43 %) |
Page: 1